Compound · Growth-hormone-related peptide fragment

AOD 9604

AOD-9604

FormatSignalis Bio lyophilized vial with 5 mg declared content, made in the United States and designated research grade.

AOD 9604 · Signalis Bio

What science explores · not a promise

  • Lipid metabolism
  • Adipocyte signaling
  • Cartilage models

What it is

AOD 9604 is a synthetic peptide designed from the terminal region of human growth hormone. It is not the complete hormone and should not be described as equivalent to it. Its design focuses on a region investigated for its relationship with lipid metabolism processes. Researchers examine signals associated with lipid breakdown and formation, distinguishing them from growth functions of the complete hormone. Selecting a molecular fragment allows specific questions about structure and function, but does not by itself establish a response in people. The distinction between a fragment and a full hormone is central to interpreting this research.

This material is research grade and is not a medicine. Published observations depend on the experimental system and its controls; they are not a promise for people. Documentation of identity, purity, and origin must be evaluated independently of any scientific hypothesis or proposed biological mechanism.

Origin

This modified synthetic fragment is inspired by the terminal region of a natural human protein. It was developed in Australia during the 1990s through academic and industrial metabolic research programs. It subsequently underwent clinical evaluation during the 2000s without becoming an approved medicine. Its laboratory identity is distinct from the complete natural hormone.

How it is studied

It is investigated in adipose cell cultures, animal metabolism models, and some cartilage models. Measurements include lipid mobilization, receptor expression, and tissue markers. Historical human studies also exist but did not establish a basis for pharmaceutical approval; they should not be confused with validation of the catalog vial or its particular batch. These studies make no promises of personal effects. Available human information has limitations and does not amount to evidence for this commercial batch. Interpretation requires reviewing controls, reproducibility, analytical identity, and differences between models before drawing scientific conclusions about the observations.

Related lessons

Dr. Peptide is a virtual presenter created with artificial intelligence; she is not a healthcare professional. This content is educational and is not medical advice, diagnosis or treatment. Decisions about your health belong with a licensed professional. Research-grade products; sale to adults 18+ only.

Follow us on Instagram · @Signalisbio